We are working with our proprietary platform to address key limitations of current gene therapy approaches to treat patients in need.
Investors 1
| Date | Name | Website |
| - | Caixa Capi... | caixacapit... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 01.03.2018 | ProteoDesign cierra una ronda de €1,7M liderada por CaixaCR,... | 01/03/2018 Nota de prensa PROTEODESIGN CIERRA UNA RONDA DE €1,7 MILLONES LIDERADA POR CAIXA CAPITA... | webcapital... |